1. Home
  2. NOTV vs GNSS Comparison

NOTV vs GNSS Comparison

Compare NOTV & GNSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • GNSS
  • Stock Information
  • Founded
  • NOTV 1974
  • GNSS 1992
  • Country
  • NOTV United States
  • GNSS United States
  • Employees
  • NOTV N/A
  • GNSS N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • GNSS Consumer Electronics/Appliances
  • Sector
  • NOTV Health Care
  • GNSS Consumer Staples
  • Exchange
  • NOTV Nasdaq
  • GNSS Nasdaq
  • Market Cap
  • NOTV 128.0M
  • GNSS 135.2M
  • IPO Year
  • NOTV 1997
  • GNSS N/A
  • Fundamental
  • Price
  • NOTV $4.06
  • GNSS $3.18
  • Analyst Decision
  • NOTV Strong Buy
  • GNSS Strong Buy
  • Analyst Count
  • NOTV 3
  • GNSS 3
  • Target Price
  • NOTV $5.92
  • GNSS $5.33
  • AVG Volume (30 Days)
  • NOTV 701.6K
  • GNSS 180.6K
  • Earning Date
  • NOTV 02-05-2025
  • GNSS 02-11-2025
  • Dividend Yield
  • NOTV N/A
  • GNSS N/A
  • EPS Growth
  • NOTV N/A
  • GNSS N/A
  • EPS
  • NOTV N/A
  • GNSS N/A
  • Revenue
  • NOTV $475,114,000.00
  • GNSS $26,587,000.00
  • Revenue This Year
  • NOTV $6.37
  • GNSS $125.62
  • Revenue Next Year
  • NOTV $5.74
  • GNSS $62.94
  • P/E Ratio
  • NOTV N/A
  • GNSS N/A
  • Revenue Growth
  • NOTV N/A
  • GNSS N/A
  • 52 Week Low
  • NOTV $1.23
  • GNSS $1.65
  • 52 Week High
  • NOTV $11.42
  • GNSS $4.04
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 49.10
  • GNSS 50.78
  • Support Level
  • NOTV $3.58
  • GNSS $3.31
  • Resistance Level
  • NOTV $4.51
  • GNSS $3.69
  • Average True Range (ATR)
  • NOTV 0.42
  • GNSS 0.23
  • MACD
  • NOTV 0.01
  • GNSS 0.01
  • Stochastic Oscillator
  • NOTV 43.08
  • GNSS 40.86

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About GNSS Genasys Inc.

Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.

Share on Social Networks: